195 related articles for article (PubMed ID: 27798157)
1. CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.
Chen D; Ireland SJ; Remington G; Alvarez E; Racke MK; Greenberg B; Frohman EM; Monson NL
J Immunol; 2016 Dec; 197(11):4257-4265. PubMed ID: 27798157
[TBL] [Abstract][Full Text] [Related]
2. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE
Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947
[TBL] [Abstract][Full Text] [Related]
3. AMPKα1 deficiency amplifies proinflammatory myeloid APC activity and CD40 signaling.
Carroll KC; Viollet B; Suttles J
J Leukoc Biol; 2013 Dec; 94(6):1113-21. PubMed ID: 23883517
[TBL] [Abstract][Full Text] [Related]
4. B cell receptor (BCR) cross-talk: CD40 engagement enhances BCR-induced ERK activation.
Mizuno T; Rothstein TL
J Immunol; 2005 Mar; 174(6):3369-76. PubMed ID: 15749869
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab.
Kemmerer CL; Pernpeintner V; Ruschil C; Abdelhak A; Scholl M; Ziemann U; Krumbholz M; Hemmer B; Kowarik MC
PLoS One; 2020; 15(7):e0235449. PubMed ID: 32716916
[TBL] [Abstract][Full Text] [Related]
6. Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma.
Blix ES; Irish JM; Husebekk A; Delabie J; Forfang L; Tierens AM; Myklebust JH; Kolstad A
BMC Cancer; 2012 Oct; 12():478. PubMed ID: 23072591
[TBL] [Abstract][Full Text] [Related]
7. Aberrant CD40-induced NF-κB activation in human lupus B lymphocytes.
Zhang W; Shi Q; Xu X; Chen H; Lin W; Zhang F; Zeng X; Zhang X; Ba D; He W
PLoS One; 2012; 7(8):e41644. PubMed ID: 22952582
[TBL] [Abstract][Full Text] [Related]
8. The expression of intercellular adhesion molecule-1 induced by CD40-CD40L ligand signaling in orbital fibroblasts in patients with Graves' ophthalmopathy.
Zhao LQ; Wei RL; Cheng JW; Cai JP; Li Y
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4652-60. PubMed ID: 20107176
[TBL] [Abstract][Full Text] [Related]
9. Monocyte and Lymphocyte Activation and Regulation in Multiple Sclerosis Patients. Therapy Effects.
González-Oria MC; Márquez-Coello M; Girón-Ortega JA; Argente J; Moya M; Girón-González JA
J Neuroimmune Pharmacol; 2019 Sep; 14(3):413-422. PubMed ID: 30649665
[TBL] [Abstract][Full Text] [Related]
10. Differential induction of nuclear factor-kappaB and activator protein-1 activity after CD40 ligation is associated with primary human hepatocyte apoptosis or intrahepatic endothelial cell proliferation.
Ahmed-Choudhury J; Russell CL; Randhawa S; Young LS; Adams DH; Afford SC
Mol Biol Cell; 2003 Apr; 14(4):1334-45. PubMed ID: 12686591
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic basis of co-stimulatory CD40-CD40L ligation mediated regulation of immune responses in cancer and autoimmune disorders.
Chand Dakal T; Dhabhai B; Agarwal D; Gupta R; Nagda G; Meena AR; Dhakar R; Menon A; Mathur R; Mona ; Yadav V; Sharma A
Immunobiology; 2020 Mar; 225(2):151899. PubMed ID: 31899051
[TBL] [Abstract][Full Text] [Related]
12. Combination of IFN beta-1a (Avonex) and mycophenolate mofetil (Cellcept) in multiple sclerosis.
Vermersch P; Waucquier N; Michelin E; Bourteel H; Stojkovic T; Ferriby D; de Seze J;
Eur J Neurol; 2007 Jan; 14(1):85-9. PubMed ID: 17222119
[TBL] [Abstract][Full Text] [Related]
13. Human Germinal Center B Cells Differ from Naïve and Memory B Cells in CD40 Expression and CD40L-Induced Signaling Response.
Huse K; Wogsland CE; Polikowsky HG; Diggins KE; Smeland EB; Myklebust JH; Irish JM
Cytometry A; 2019 Apr; 95(4):442-449. PubMed ID: 30838773
[TBL] [Abstract][Full Text] [Related]
14. CD40 activates NF-kappa B and c-Jun N-terminal kinase and enhances chemokine secretion on activated human hepatic stellate cells.
Schwabe RF; Schnabl B; Kweon YO; Brenner DA
J Immunol; 2001 Jun; 166(11):6812-9. PubMed ID: 11359840
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
Filippini G; Del Giovane C; Vacchi L; D'Amico R; Di Pietrantonj C; Beecher D; Salanti G
Cochrane Database Syst Rev; 2013 Jun; (6):CD008933. PubMed ID: 23744561
[TBL] [Abstract][Full Text] [Related]
16. The Act1 D10N missense variant impairs CD40 signaling in human B-cells.
Yu N; Lambert S; Bornstein J; Nair RP; Enerbäck C; Elder JT
Genes Immun; 2019 Jan; 20(1):23-31. PubMed ID: 29302052
[TBL] [Abstract][Full Text] [Related]
17. Elevated CD40 ligand expressing blood T-cell levels in multiple sclerosis are reversed by interferon-beta treatment.
Teleshova N; Bao W; Kivisäkk P; Ozenci V; Mustafa M; Link H
Scand J Immunol; 2000 Mar; 51(3):312-20. PubMed ID: 10736102
[TBL] [Abstract][Full Text] [Related]
18. Signaling via toll-like receptor 4 and CD40 in B cells plays a regulatory role in the pathogenesis of multiple sclerosis through interleukin-10 production.
Okada Y; Ochi H; Fujii C; Hashi Y; Hamatani M; Ashida S; Kawamura K; Kusaka H; Matsumoto S; Nakagawa M; Mizuno T; Takahashi R; Kondo T
J Autoimmun; 2018 Mar; 88():103-113. PubMed ID: 29146546
[TBL] [Abstract][Full Text] [Related]
19. Utilization of peginterferon-β-1a in the real-world practice for relapsing-remitting multiple sclerosis.
Moccia M; Santoni L; Vaccari I; Affinito G; Caliendo D; Rubba F; Lanzillo R; Triassi M; Brescia Morra V; Palladino R
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(1):411-418. PubMed ID: 38235893
[TBL] [Abstract][Full Text] [Related]
20. CD40 induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-kappaB and of NF-kappaB-mediated de novo synthesis of IRF-1.
Moschonas A; Kouraki M; Knox PG; Thymiakou E; Kardassis D; Eliopoulos AG
Mol Cell Biol; 2008 Oct; 28(20):6208-22. PubMed ID: 18694960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
